1. At a Glance

Lotus Eye Hospital & Institute Ltd (LEHIL) is a listed chain of eye hospitals, headquartered in Coimbatore, operating 8 centers across Tamil Nadu and Kerala. They specialize in super-specialty ophthalmology services—from basic LASIK to robotic cataract surgery. Despite performing nearly 9,703 eye surgeries in FY23 and steady expansion, the company’s financial “vision” looks blurred: sales just ₹50 Cr, profits under ₹1 Cr, and valuation at 432x P/E.

2. Business Overview – What They Do

• Hospitals: 8 centers (Coimbatore, Tiruppur, Salem, Mettupalayam, and 2 in Kochi).
• Services Offered:
  • ReLEx SMILE, LASIK, Touchfree Laser, Robotic Femto Cataract
  • Paediatric Eye Care, Squint Surgery, Ocular Prosthesis
  • Retinal/Diabetic Eye Care, Glaucoma, Keratoconus, Neuro-Ophthalmology
• Revenue Mix FY23:
  • Medical Services: 71%
  • Optical & Lenses: 19%
  • Pharmacy: 8%
  • Others: 2%

Basically, think Apollo Hospitals but shrunk down to just eyeballs.

3. Scale & Operations

• Annual Surgeries: FY23 – 9,703 (vs. 8,076 in FY22).
• Latest Expansion: 8th center at Saravanampatti (Coimbatore) in July 2023.
• Treatment Breadth: Covers everything from refractive corrections to retinal care, making it a full-service eye hospital chain.

Question: Is the market seeing it as the next “Max Healthcare for eyes” or just overpaying for a regional player?

4. Financial Performance Snapshot (FY25)

Verdict: Looks more like a non-profit trust masquerading as a listed company.

5. Quarterly Performance (Jun’25)

Comment: At least the June quarter saw profits back in focus.

6. Long-Term Trends

Translation: